Clinical Trials Directory

Trials / Unknown

UnknownNCT05753969

The Efficacy of "Mindtesion"is Measuring Attentional and the Startle Response Dysregulation in Children and Adolescents Suffering From Attention Deficit Disorder: With and Without Medication.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Geha Mental Health Center · Academic / Other
Sex
All
Age
7 Years – 18 Years
Healthy volunteers
Accepted

Summary

Double blind, placebo-controlled clinical study designed to evaluate Mindtension device and Protocol as a diagnostic tool in children diagnosed with ADHD

Detailed description

Mindtension device measures the orbicularis muscle response to auditory stimuli, the device is backed up by an algorithm that calculate the several parameters of startle reflex such as the Paired-pulse inhibition (PPI), Habituation, and startle related indices. Data collected by the device is used to evaluate the subject levels of attention, Hyperarousal and Impulsivity, by means of physiological EMG signals of the startle response. Evaluating baseline differences in these parameters between ADHD and age matched healthy controls, and the possible improvement after psychostimulant medications.

Conditions

Interventions

TypeNameDescription
DEVICEMT1 DevicePre-and post-evaluation in MT1 device following stimulant treatment or placebo control

Timeline

Start date
2021-02-23
Primary completion
2023-12-31
Completion
2024-02-28
First posted
2023-03-03
Last updated
2023-03-03

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT05753969. Inclusion in this directory is not an endorsement.